NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Kidney protein profiling of Wilms' tumor patients by analysis of formalin-fixed paraffin-embedded tissue samples.

Author(s): Hammer E, Ernst FD, Thiele A, Karanam NK, Kujath C, Evert M, Völker U, Barthlen W

Publication: Clin Chim Acta, 2014, Vol. 433, Page 235-41

PubMed ID: 24680863 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of using formalin-fixed, paraffin-embedded (FFPE) rather than frozen kidney specimens and inter- and intraindividual variability on protein identification by mass spectrometry (MS) in normal adjacent and kidney tumor specimens. The effects of tumor status on protein identification by MS and immunohistochemistry (IHC) were also examined.

Conclusion of Paper

15% more proteins were identified using frozen specimens than FFPE specimens by MS. However, the variability in protein identification between FFPE and frozen specimens was comparable to that observed between frozen replicates, and intraindividual variability was slightly less than interindividual variability. Using only FFPE specimens, 259 proteins were found to be differentially expressed by MS between normal adjacent and tumor specimens, with most proteins having lower expression in the tumor tissue.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of using FFPE rather than frozen specimens and inter- and intraindividual variability on protein identification in normal adjacent and kidney tumor specimens. 3 kidney tumor and normal adjacent paired specimens were used for the comparison between specimens snap-frozen in liquid nitrogen and FFPE specimens.

    Summary of Findings:

    66% of the 1731 proteins identified by MS were found in both FFPE and frozen specimen. An additional 24% (420 of 1731) of proteins were found just in frozen specimens, and 9% (154 of 1731) were found just in FFPE specimens. Finally, 72% of the proteins found to have >2 fold difference in expression between frozen Wilms’ tumor and normal adjacent tissue were also found to be differentially expressed between FFPE tumor and normal adjacent specimens from the same patient. 66% of the proteins identified were found in all three replicates of the same frozen kidney specimen, and 62% of proteins identified were common among all three patients.

    Biospecimens
    Preservative Types
    • Frozen
    • Formalin
    Diagnoses:
    • Neoplastic - Pediatric
    • Neoplastic - Normal Adjacent
    • Neoplastic - Carcinoma
    • Neoplastic - Other
    Platform:
    AnalyteTechnology Platform
    Peptide MS/MS
    Protein MS/MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation Formalin (buffered)
    Snap frozen
    Biospecimen Aliquots and Components Biospecimen heterogeneity Intratumoral sampling (exact positions not specified)
    Preaquisition Diagnosis/ patient condition Wilms' tumor
    Normal adjacent
  2. Study Purpose

    The purpose of this study was to determine the effects tumor status and analysis method on protein expression in FFPE kidney specimens. 7 FFPE specimens from pediatric patients (1 year 7 months to 8 years 9 months of age) were used to compare protein expression between Wilms' tumor and normal adjacent specimens.

    Summary of Findings:

    The authors identified 259 proteins (29% of 879) with >2 fold differential expression between normal adjacent and tumor tissue by MS. Most of these proteins (183 of 259) were expressed at lower levels in the tumor tissue and tended to be involved in metabolism. IHC staining confirmed expression differences for Ezrin, Sodium/hydrogen Exchanger Regulatory Factor (NHERF1), transforming growth factor beta (TGF-β1), collagen type 1 alpha 1 (Col1A1), vimentin, LIM and SH3 domain protein 1 (LASP1), and collagen.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Normal Adjacent
    • Neoplastic - Pediatric
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein MS/MS
    Protein Immunohistochemistry
    Peptide MS/MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    MS/MS Specific Technology platform IHC
    Immunohistochemistry Specific Targeted peptide/protein Ezrin
    NHERF1
    TGF-β1
    Col1A1
    Vimentin
    LASP1
    Collagen
    Preaquisition Diagnosis/ patient condition Wilms’ tumor
    Normal adjacent tissue

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...